Global Patient-derived Xenograft (PDX) Models Market Growth (Status and Outlook) 2024-2031

Report ID: 1780562 | Published Date: Jan 2026 | No. of Page: 114 | Base Year: 2025 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Patient-derived Xenograft (PDX) Models Market Size 2017-2028
        2.1.2 Patient-derived Xenograft (PDX) Models Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Patient-derived Xenograft (PDX) Models Segment by Type
        2.2.1 Mouse Model
        2.2.2 Rat Model
    2.3 Patient-derived Xenograft (PDX) Models Market Size by Type
        2.3.1 Patient-derived Xenograft (PDX) Models Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
    2.4 Patient-derived Xenograft (PDX) Models Segment by Application
        2.4.1 Preclinical Drug development
        2.4.2 Biomarker Analysis
    2.5 Patient-derived Xenograft (PDX) Models Market Size by Application
        2.5.1 Patient-derived Xenograft (PDX) Models Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
3 Patient-derived Xenograft (PDX) Models Market Size by Player
    3.1 Patient-derived Xenograft (PDX) Models Market Size Market Share by Players
        3.1.1 Global Patient-derived Xenograft (PDX) Models Revenue by Players (2020-2022)
        3.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2020-2022)
    3.2 Global Patient-derived Xenograft (PDX) Models Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Patient-derived Xenograft (PDX) Models by Regions
    4.1 Patient-derived Xenograft (PDX) Models Market Size by Regions (2017-2022)
    4.2 Americas Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
    4.3 APAC Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
    4.4 Europe Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
    4.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
    5.2 Americas Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
    5.3 Americas Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022)
    6.2 APAC Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
    6.3 APAC Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Patient-derived Xenograft (PDX) Models by Country (2017-2022)
    7.2 Europe Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
    7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Patient-derived Xenograft (PDX) Models by Region (2017-2022)
    8.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
    8.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Patient-derived Xenograft (PDX) Models Market Forecast
    10.1 Global Patient-derived Xenograft (PDX) Models Forecast by Regions (2023-2028)
        10.1.1 Global Patient-derived Xenograft (PDX) Models Forecast by Regions (2023-2028)
        10.1.2 Americas Patient-derived Xenograft (PDX) Models Forecast
        10.1.3 APAC Patient-derived Xenograft (PDX) Models Forecast
        10.1.4 Europe Patient-derived Xenograft (PDX) Models Forecast
        10.1.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Forecast
    10.2 Americas Patient-derived Xenograft (PDX) Models Forecast by Country (2023-2028)
        10.2.1 United States Patient-derived Xenograft (PDX) Models Market Forecast
        10.2.2 Canada Patient-derived Xenograft (PDX) Models Market Forecast
        10.2.3 Mexico Patient-derived Xenograft (PDX) Models Market Forecast
        10.2.4 Brazil Patient-derived Xenograft (PDX) Models Market Forecast
    10.3 APAC Patient-derived Xenograft (PDX) Models Forecast by Region (2023-2028)
        10.3.1 China Patient-derived Xenograft (PDX) Models Market Forecast
        10.3.2 Japan Patient-derived Xenograft (PDX) Models Market Forecast
        10.3.3 Korea Patient-derived Xenograft (PDX) Models Market Forecast
        10.3.4 Southeast Asia Patient-derived Xenograft (PDX) Models Market Forecast
        10.3.5 India Patient-derived Xenograft (PDX) Models Market Forecast
        10.3.6 Australia Patient-derived Xenograft (PDX) Models Market Forecast
    10.4 Europe Patient-derived Xenograft (PDX) Models Forecast by Country (2023-2028)
        10.4.1 Germany Patient-derived Xenograft (PDX) Models Market Forecast
        10.4.2 France Patient-derived Xenograft (PDX) Models Market Forecast
        10.4.3 UK Patient-derived Xenograft (PDX) Models Market Forecast
        10.4.4 Italy Patient-derived Xenograft (PDX) Models Market Forecast
        10.4.5 Russia Patient-derived Xenograft (PDX) Models Market Forecast
    10.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Forecast by Region (2023-2028)
        10.5.1 Egypt Patient-derived Xenograft (PDX) Models Market Forecast
        10.5.2 South Africa Patient-derived Xenograft (PDX) Models Market Forecast
        10.5.3 Israel Patient-derived Xenograft (PDX) Models Market Forecast
        10.5.4 Turkey Patient-derived Xenograft (PDX) Models Market Forecast
        10.5.5 GCC Countries Patient-derived Xenograft (PDX) Models Market Forecast
    10.6 Global Patient-derived Xenograft (PDX) Models Forecast by Type (2023-2028)
    10.7 Global Patient-derived Xenograft (PDX) Models Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Crown Bioscience
        11.1.1 Crown Bioscience Company Information
        11.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Offered
        11.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Crown Bioscience Main Business Overview
        11.1.5 Crown Bioscience Latest Developments
    11.2 Champions Oncology
        11.2.1 Champions Oncology Company Information
        11.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Offered
        11.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Champions Oncology Main Business Overview
        11.2.5 Champions Oncology Latest Developments
    11.3 Wuxi Apptec
        11.3.1 Wuxi Apptec Company Information
        11.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Offered
        11.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Wuxi Apptec Main Business Overview
        11.3.5 Wuxi Apptec Latest Developments
    11.4 The Jackson Laboratory
        11.4.1 The Jackson Laboratory Company Information
        11.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Offered
        11.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 The Jackson Laboratory Main Business Overview
        11.4.5 The Jackson Laboratory Latest Developments
    11.5 EPO Berlin-Buch
        11.5.1 EPO Berlin-Buch Company Information
        11.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Offered
        11.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 EPO Berlin-Buch Main Business Overview
        11.5.5 EPO Berlin-Buch Latest Developments
    11.6 Oncodesign
        11.6.1 Oncodesign Company Information
        11.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Offered
        11.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Oncodesign Main Business Overview
        11.6.5 Oncodesign Latest Developments
    11.7 Xentech
        11.7.1 Xentech Company Information
        11.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Offered
        11.7.3 Xentech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Xentech Main Business Overview
        11.7.5 Xentech Latest Developments
    11.8 Envigo
        11.8.1 Envigo Company Information
        11.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Offered
        11.8.3 Envigo Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Envigo Main Business Overview
        11.8.5 Envigo Latest Developments
    11.9 Charles River Laboratories
        11.9.1 Charles River Laboratories Company Information
        11.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Offered
        11.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Charles River Laboratories Main Business Overview
        11.9.5 Charles River Laboratories Latest Developments
    11.10 Pharmatest Services
        11.10.1 Pharmatest Services Company Information
        11.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Offered
        11.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Pharmatest Services Main Business Overview
        11.10.5 Pharmatest Services Latest Developments
    11.11 Urosphere
        11.11.1 Urosphere Company Information
        11.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Offered
        11.11.3 Urosphere Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Urosphere Main Business Overview
        11.11.5 Urosphere Latest Developments
    11.12 MEDICILON
        11.12.1 MEDICILON Company Information
        11.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Offered
        11.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 MEDICILON Main Business Overview
        11.12.5 MEDICILON Latest Developments
    11.13 Horizon Discovery
        11.13.1 Horizon Discovery Company Information
        11.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Offered
        11.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Horizon Discovery Main Business Overview
        11.13.5 Horizon Discovery Latest Developments
    11.14 Shanghai Model Organisms Center
        11.14.1 Shanghai Model Organisms Center Company Information
        11.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Offered
        11.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Shanghai Model Organisms Center Main Business Overview
        11.14.5 Shanghai Model Organisms Center Latest Developments
    11.15 GemPharmatech
        11.15.1 GemPharmatech Company Information
        11.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Offered
        11.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 GemPharmatech Main Business Overview
        11.15.5 GemPharmatech Latest Developments
    11.16 LIDE Biotech
        11.16.1 LIDE Biotech Company Information
        11.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Offered
        11.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 LIDE Biotech Main Business Overview
        11.16.5 LIDE Biotech Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Patient-derived Xenograft (PDX) Models Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Mouse Model
    Table 3. Major Players of Rat Model
    Table 4. Patient-derived Xenograft (PDX) Models Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
    Table 7. Patient-derived Xenograft (PDX) Models Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
    Table 10. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Player (2020-2022)
    Table 12. Patient-derived Xenograft (PDX) Models Key Players Head office and Products Offered
    Table 13. Patient-derived Xenograft (PDX) Models Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Patient-derived Xenograft (PDX) Models Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Country (2017-2022)
    Table 20. Americas Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
    Table 22. Americas Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
    Table 24. APAC Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Region (2017-2022)
    Table 26. APAC Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
    Table 28. APAC Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
    Table 30. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Country (2017-2022)
    Table 32. Europe Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
    Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Patient-derived Xenograft (PDX) Models
    Table 43. Key Market Challenges & Risks of Patient-derived Xenograft (PDX) Models
    Table 44. Key Industry Trends of Patient-derived Xenograft (PDX) Models
    Table 45. Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Patient-derived Xenograft (PDX) Models Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Patient-derived Xenograft (PDX) Models Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Patient-derived Xenograft (PDX) Models Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Crown Bioscience Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 52. Crown Bioscience Patient-derived Xenograft (PDX) Models Product Offered
    Table 53. Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Crown Bioscience Main Business
    Table 55. Crown Bioscience Latest Developments
    Table 56. Champions Oncology Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 57. Champions Oncology Patient-derived Xenograft (PDX) Models Product Offered
    Table 58. Champions Oncology Main Business
    Table 59. Champions Oncology Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Champions Oncology Latest Developments
    Table 61. Wuxi Apptec Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 62. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Offered
    Table 63. Wuxi Apptec Main Business
    Table 64. Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Wuxi Apptec Latest Developments
    Table 66. The Jackson Laboratory Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 67. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Offered
    Table 68. The Jackson Laboratory Main Business
    Table 69. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. The Jackson Laboratory Latest Developments
    Table 71. EPO Berlin-Buch Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 72. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Offered
    Table 73. EPO Berlin-Buch Main Business
    Table 74. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. EPO Berlin-Buch Latest Developments
    Table 76. Oncodesign Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 77. Oncodesign Patient-derived Xenograft (PDX) Models Product Offered
    Table 78. Oncodesign Main Business
    Table 79. Oncodesign Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. Oncodesign Latest Developments
    Table 81. Xentech Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 82. Xentech Patient-derived Xenograft (PDX) Models Product Offered
    Table 83. Xentech Main Business
    Table 84. Xentech Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Xentech Latest Developments
    Table 86. Envigo Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 87. Envigo Patient-derived Xenograft (PDX) Models Product Offered
    Table 88. Envigo Main Business
    Table 89. Envigo Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Envigo Latest Developments
    Table 91. Charles River Laboratories Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 92. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Offered
    Table 93. Charles River Laboratories Main Business
    Table 94. Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Charles River Laboratories Latest Developments
    Table 96. Pharmatest Services Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 97. Pharmatest Services Patient-derived Xenograft (PDX) Models Product Offered
    Table 98. Pharmatest Services Main Business
    Table 99. Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Pharmatest Services Latest Developments
    Table 101. Urosphere Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 102. Urosphere Patient-derived Xenograft (PDX) Models Product Offered
    Table 103. Urosphere Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Urosphere Main Business
    Table 105. Urosphere Latest Developments
    Table 106. MEDICILON Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 107. MEDICILON Patient-derived Xenograft (PDX) Models Product Offered
    Table 108. MEDICILON Main Business
    Table 109. MEDICILON Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. MEDICILON Latest Developments
    Table 111. Horizon Discovery Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 112. Horizon Discovery Patient-derived Xenograft (PDX) Models Product Offered
    Table 113. Horizon Discovery Main Business
    Table 114. Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 115. Horizon Discovery Latest Developments
    Table 116. Shanghai Model Organisms Center Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 117. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Offered
    Table 118. Shanghai Model Organisms Center Main Business
    Table 119. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 120. Shanghai Model Organisms Center Latest Developments
    Table 121. GemPharmatech Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 122. GemPharmatech Patient-derived Xenograft (PDX) Models Product Offered
    Table 123. GemPharmatech Main Business
    Table 124. GemPharmatech Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 125. GemPharmatech Latest Developments
    Table 126. LIDE Biotech Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
    Table 127. LIDE Biotech Patient-derived Xenograft (PDX) Models Product Offered
    Table 128. LIDE Biotech Main Business
    Table 129. LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 130. LIDE Biotech Latest Developments
List of Figures
    Figure 1. Patient-derived Xenograft (PDX) Models Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type in 2021
    Figure 7. Patient-derived Xenograft (PDX) Models in Preclinical Drug development
    Figure 8. Global Patient-derived Xenograft (PDX) Models Market: Preclinical Drug development (2017-2022) & ($ Millions)
    Figure 9. Patient-derived Xenograft (PDX) Models in Biomarker Analysis
    Figure 10. Global Patient-derived Xenograft (PDX) Models Market: Biomarker Analysis (2017-2022) & ($ Millions)
    Figure 11. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
    Figure 12. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Player in 2021
    Figure 13. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Patient-derived Xenograft (PDX) Models Value Market Share by Country in 2021
    Figure 19. Americas Patient-derived Xenograft (PDX) Models Consumption Market Share by Type in 2021
    Figure 20. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
    Figure 21. United States Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Region in 2021
    Figure 26. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
    Figure 27. China Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Country in 2021
    Figure 34. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Type in 2021
    Figure 35. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
    Figure 36. Germany Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
    Figure 44. Egypt Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 53. United States Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 57. China Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 61. India Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 64. France Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 65. UK Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Patient-derived Xenograft Models Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Patient-derived Xenograft Models Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Patient-derived Xenograft Models Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports